A Phase 2, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Assess the Safety, Efficacy, and Tolerability of ARGX-117 in Improving Allograft Function in Recipients of a Deceased Donor Renal Allograft at Risk for Delayed Graft Function
Obert
- Codi protocol: ARGX-117-2201
- Codi EudraCT: 2022-503091-89-00
- Grup de recerca: Nefrologia i Trasplantament Renal
- Servei: Nefrologia
- Investigador/a principal: Moreso Mateos, Francesc
- Fase: Fase II
- Estat: Reclutant voluntaris